1. Histopathological and molecular profiling of lung adenocarcinoma skin metastases reveals specific features
- Author
-
Olivier Tiffet, David Laville, Cyril Habougit, Vanessa Da Cruz, Tiphanie Picot, Fabien Forest, Michel Peoc'h, Jean-Luc Perrot, Violaine Yvorel, Francois Casteillo, Sandrine Bard-Sorel, and William Godard
- Subjects
Adult ,Male ,Pathology ,medicine.medical_specialty ,Lung Neoplasms ,Skin Neoplasms ,Histology ,Adenocarcinoma of Lung ,medicine.disease_cause ,Pathology and Forensic Medicine ,Cohort Studies ,Exon ,PD-L1 ,Biomarkers, Tumor ,medicine ,Humans ,Aged ,Retrospective Studies ,Lung ,biology ,business.industry ,Retrospective cohort study ,General Medicine ,Middle Aged ,medicine.disease ,medicine.anatomical_structure ,Egfr mutation ,biology.protein ,Adenocarcinoma ,Female ,Thyroid Transcription Factor ,KRAS ,business - Abstract
AIMS Little is known regarding the histopathological and molecular features of lung adenocarcinoma skin metastases. Our study is the largest, to our knowledge, to comprehensively explore these to date. METHODS AND RESULTS We performed a retrospective cohort study analysing 42 lung adenocarcinoma skin metastasis samples obtained from a database of 2659 lung adenocarcinomas collected between 2010 and 2020. EGFR exon 19 deletion was detected in one patient and KRAS mutations were detected in 12 (33.3%) patients. The programmed cell death ligand 1 (PD-L1) tumour proportion score was
- Published
- 2021